Aarhus University Seal

PhD defence: Karoline Kondrup Torstensson

Methylation patterns in blood may predict disease progression in metastatic prostate cancer

Info about event

Time

Thursday 19 November 2026,  at 13:00 - 15:00

Location

Auditorium, Ground floor, Building D/E, Aarhus University Hospital

On Thursday 19 November 2026 at 13:00, Karoline Kondrup Torstensson defends her PhD dissertation entitled “Cell-Free DNA Methylome Profiling for Discovery of Novel Biomarkers in Advanced Prostate Cancer”. 

Can a simple blood test predict which patients with metastatic prostate cancer will progress rapidly, even before treatment begins? A PhD project from Aarhus University, Health, has investigated this question by exploring whether DNA methylation patterns in blood can provide information about patients’ prognosis.

Tumor cells may leave traces of their DNA in the bloodstream, providing valuable clues about the disease. Using advanced sequencing technologies, the project analyzed DNA methylation patterns in pretreatment blood samples and developed new approaches to detect tumor-derived DNA in patients with metastatic prostate cancer. The project showed that patients with detectable tumor-derived DNA or higher levels of tumor-derived DNA in the blood were at greater risk of rapid disease progression.
The project provides insight into the potential of blood-based analyses to assess patients’ prognosis and may ultimately contribute to more personalized clinical management of patients with metastatic prostate cancer in the future.

The summary is written by the PhD student.

The defence is public and takes place Auditorium, Ground floor, Building D/E, Aarhus University Hospital. Please see the press release for more information. 

Contact

PhD student Karoline Kondrup Torstensson
Mail: kkt@clin.au.dk 
Phone: +45 29462531

Read full press release